Skip to main content
. 2015 May 5;10(5):e0125436. doi: 10.1371/journal.pone.0125436

Table 1. Summary table of correlation of male circumcision status and HIV acquisition.

Study/ study design sites population size analyzed in cir./unc. group follow up duration proportion with circumcised male HIV(+) rate in circumcised group HIV(+) rate in uncircumcised group Unadjusted RR# (95% CI & ) Adjusted RR(95% CI)
Studies concerning HIV acquisition from female to male
Auvert2005 /RCT South Africa male of general population 1546/1582 21mons 49% 0.85 per 100 pyo* 2.1 per 100 pyo 0.40 (0.24–0.68) 0.39 (0.23–0.66)
Bailey2007 /RCT Kisumu, Kenya HIV(-) male 1391/1393 24mons 50% 2.1% (1.2–3.0) 4.2% (3.0–5.4) 0.47 (0.28–0.78) 0.41 (0.24–0.70)
Gray2007 /RCT Rakai, Uganda HIV(-) male 2474/2522 24mons 50% 0.66 per 100 pyo 1.33 per 100 pyo 0.49 (0.28–0.84) 0.49 (0.29–0.81)
Cameron1989 /P. Cohort Nairobi, Kenya STD clinic visitors 214/79 73% 0.10 (0.04–0.22) 0.12 (0.04–0.33)
Lavreys1999 /P. Cohort Mombasa,Kenya HIV(-) male 651/95 20mons 13% 2.50 per 100 pyo 1.8 per 100 pyo 0.42 (0.22–0.81)
Wawer1999 /P. Cohort Rakai, Uganda Subgroup1(S1): HIV(-) male 409/1635 20mons 20% 1.40 per 100 pyo 0.97 (0.36–2.25)
Subgroup2(S2): HIV(-) male 346/1961 20mons 15% 0.70 per 100 pyo 0.45 (0.09–1.40)
Ronaid2000 /P. Cohort Rakai, Uganda HIV(-) male 908/4608 49mons 16% 1.10 per 100 pyo 1.8 per 100 pyo 0.61 (0.37–0.97) 0.53(0.33–0.87))
Reynolds2004 /P. Cohort Pune, India HIV(-) male 191/2107 12mons 8% 0.70 per 100 pyo 5.50 per 100 pyo 0.13 (0.02–0.47) 0.15 (0.04–0.62)
Gray2012/P. Cohort Rakai, Uganda HIV(-) male 3198/402 4.79years 89% 0.50 per 100 pyo 1.93per 100 pyo 0.27 (0.16–0.44) 0.27 (0.16–0.45)
Studies concerning HIV acquisition from male to female
Wawer2009 /RCT Rakai, Uganda Female with HIV(+) partners 92/67 24mons 58% 18% (17/92) 12% (8/67) 1.58 (0.68–3.66) 1.49 (0.62–3.57)
Kapiga1998 /P. Cohort Dar es Salaam, Tanzania Family planning clinic visitors 1022/22 34mons 98% 2.60 per 100 pyo 9.20 per 100 pyo 0.28 (0.09–0.89) 0.29 (0.09–0.97)
Reynolds2006 /P. Cohort Rakai, Uganda Couples with HIV(+)males 13% 6.60 per 100 pyo 10.3 per 100 pyo 0.67 (0.45–1.00)
Turner2007 /P. Cohort Zimbabwe Family planning clinic visitors/STD clinic visitors/sex workers 989/3249 24mons 30% 2.03 per 100 pyo 2.96 per 100 pyo 0.69 (0.48–0.99) 0.78 (0.53–1.14)
Baeten2010/P. Cohort 14 sites in east/southern Africa Couples with HIV(+) males 374/722 24mons 34% 2.72 per 100 pyo 4.38 per 100 pyo 0.62 (0.35–1.10) 0.56 (0.30–1.05)§

RCT: randomised controlled trial. P. Cohort: prospective cohort study.

*Person-years of observation.

#Risk ratio is incidence rate (or hazard) ratios for RCT and Cohort shown.

&Confidence interval.

○Hazard ratio adjusted for sexual behaviour that increased slightly in the intervention group, condom use, and health-seeking behavior.

◎Hazard ratio adjusted for non-adherence to treatment and excluding four men found to be seropositive at enrolment.

⊕Rate ratio adjusted for age, marital status, and sexual risk behaviours at enrolment.

♂Adjusting factors were not achieved.

⊙Rate ratio adjusted for age, marital status, sexual partners in past year, sex for money, condom use and syphilis.

♀Rate ratio adjusted for Hindu/non-Hindu religion, level of education, living with family; and time-dependent covariates: calendar year,age group, marital status, multiple sex partners, number of female sex-worker partners (0, 1, 2–9, or10~), condom use, tattoos, and medical injections.

☆Hazard Ratio adjusted for sociodemographic characteristics at the last trial visit and time-dependent sexual behaviors during posttrial follow up.

※Hazard ratio adjusted for age and condom useage.

▽Rate ratio adjusted for age, marital status, gonorrhea/candidiasis at baseline, number of sexual partners and alcohol consumption during the follow-up period.

◇Hazard ratio adjusted for age, age at coital debut, contraceptive method, husband′s employment status, education, number of partners in past 3 months, and a product-interaction term between time and number of partners in past 3 months.

§Hazard ratio adjusted for male partner HIV-1 plasma viral load and censored at male partner antiretroviral therapy initiation.

№Dates were not available.